Global Biomaterial Wound Dressing Market - 2022-2029

Market Overview

Biomaterial Wound Dressing Market is expected to grow at a CAGR of 10.8% during the forecasting period (2022-2029).

Biomaterial wound healing can be categorized in several ways, depending on its chemical nature, source, type of dressing, or application. Synthetic biomaterials consist of organic and inorganic polymers. In contrast, natural biomaterials include biological products derived from plant, fungal, animal, or bacterial sources that can, in turn, be divided into proteins, polysaccharides, or macromolecules combining proteins and polysaccharides. The rising incidence of chronic wounds such as ulcers is significantly creating the demand for wound dressing products, augmenting the market growth. The rising incidence of wound infection and an increasing number of surgeries also demand advanced and traditional wound care products.

Market Dynamics: Rising incidence of wound infection drives the market's growth during the forecast period.

The increasing incidence of wound infection due to poor hygiene, diabetes, obesity, and others contributes to the growth of the wound dressing market. The wound dressing is used to reduce the wound infection by placing it on the infection area. Infections are inconvenient and painful and lead to failure or delay in wound healing. In some cases, wound infection is very severe, causing necrotizing cellulitis or fasciitis; it spreads into the local bone, tendon, or joint tissues; systemic disease or metastatic spread to the spine or other distant sites.

Moreover, the global biomaterial wound dressing market is experiencing significant growth due to the increasing number of surgeries worldwide. Moreover, the increasing number of plastic surgeries is driving the wound dressing market due to its application for wound healing in plastic surgeries. The increasing number of surgical and nonsurgical cosmetic procedures in the United States is significant. For instance, in 2021, more than 5.5 million procedures involved toxins and fillers, and 491 thousand performed surgeries in the United States.

Market Segmentation: Hydrocolloid dressing segment accounted for the highest share in global biomaterial wound dressing market.

Hydrocolloid dressings are bandages made of gel-forming agents such as gelatin and pectin that form a moist environment with the body that promotes healing. The hydrocolloid dressings absorb fluid from the wound and are generally recommended for minor burns, leg ulcers, pressure sores, and traumatic injuries. Such dressings can be kept for several days, as it slowly aids the healing process and maintains the wound environment. Hydrocolloid dressings are available in the market in various shapes and sizes. The widely used hydrocolloid dressing brands available in the market include Duoderm GCF, Comfeel, Actiderm, and Hydrosol.

The biomaterial wound dressing market is classified into wounds, burns, ulcers, and others by the application. The wound segment held a significant share in the market growth. Wounds dominated the biomaterial wound dressing market in the forecast period. Surgical wound contributes majorly to segmental growth across the globe. A surgical wound is a cut that is generally made by using a scalpel during the surgical procedure. There are primarily two types of surgical wounds following surgery, including incisional wounds and excisional wounds. Incisional wounds are made by cutting through fat, skin, and muscle, enabling body parts to be removed or repaired. The biomaterial wound dressings play an important role in controlling any postoperative bleeding, offering protection to newly developed tissue, and easing pain.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market dominated the largest market share in the global biomaterial wound dressing market in the forecast period. Factors augmenting the North American market's growth include the increasing incidence of pressure ulcers and a rising number of burning injury cases. Further, the rising number of surgical procedures and the presence of major players are also estimated to contribute to the market's growth.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally due to the growing aging population coupled with the increasing prevalence of ulcers, increasing number of burn cases, and the rising prevalence of diabetes across the Asia Pacific economies. By 2020, there were 255 million elders, representing at least 17.8% of the entire Chinese population. With the age dynamics, ulcer cases among the population of Asia-Pacific are expected to grow, which is expected to increase the chances of wounds.

Competitive Landscape:

The biomaterial wound dressing market is dominated by a few companies. Some of the key players in the market's growth include 3M Company, ConvaTec Group PLC, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global biomaterial wound dressing market. In August 2022, The 3M Health Care's medical solutions business announced upgrades to advance the delivery of certain wound care technologies. This new biomaterial wound unit, named 3M VAC Ulta therapy unit, was introduced at no increased cost to the customer. It is used for patients with open soft tissue wounds to help cleanse and stimulate the formation of granulation tissue. This kit helps to soften, solubilize, disrupt, and remove thick and non-viable tissue when immediate wound cleansing is needed. 3M company offers a wide range of wound care solutions. 3M developed the new dressing kit to simplify various dressing applications. In January 2022, ConvaTec Group entered into a definitive agreement to acquire Triad Life Sciences Inc, which develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. This acquisition strengthens Convatec's Advanced Wound Care position in the United States and provides an innovative technology platform that enhances advanced wound management and patient outcomes.

COVID-19 Impact: Negative impact on the global biomaterial wound dressing market.

The outbreak of the COVID-19 pandemic is expected to derail the biomaterial wound dressing market's growth in 2020. The decline in accidents and the number of hospital visits is the major factor that has negatively impacted the biomaterial wound dressing market growth in 2020. However, the market is expected to have a negative impact due to the decrease in road accidents due to strict lockdown conditions and work-from-home facilities to avoid contamination of COVID-19.